30/05/2024
"French, who visited Somai’s facility, commented: “I am excited to see more brands entering the market, especially ones that take the quality of the medicine very seriously. However, exciting as that is, it pales in comparison to the larger issue of the stigma around cannabis in the UK which is preventing many from knowing that they can legally access cannabis.
“Until the NHS prescribes cannabis, the vast majority of patients in the UK will miss out and face being criminalised.
“As it stands, patients with a prescription have opened up a new front on the war on drugs, yet we are still on the front line, bearing the brunt of the workload, and we desperately need more support from the industry. Not just access, but help raising awareness.
“Patient-centred medicine is vital and I was pleased to see Somai invite patients to see the facility. This gives me hope that the industry is realising that the more it supports patients and patient advocacy, the better off it will be in the long run.”
UK medical cannabis patients are facing multiple challenges that are preventing the adoption of the legal market. From stigmatisation and supply bottlenecks to inconsistent medicine quality and high consultation costs, […]
